Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: a new look at hallmarks of breast cancer
R Abdollahzadeh, A Daraei, Y Mansoori… - Journal of cellular …, 2019 - Wiley Online Library
Breast cancer (BC) is the most frequently occurring malignancy in women worldwide.
Despite the substantial advancement in understanding the molecular mechanisms and …
Despite the substantial advancement in understanding the molecular mechanisms and …
Proteasomes and several aspects of their heterogeneity relevant to cancer
AV Morozov, VL Karpov - Frontiers in Oncology, 2019 - frontiersin.org
The life of every organism is dependent on the fine-tuned mechanisms of protein synthesis
and breakdown. The degradation of most intracellular proteins is performed by the ubiquitin …
and breakdown. The degradation of most intracellular proteins is performed by the ubiquitin …
METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis
S Zhuang, Y Ma, Y Zeng, C Lu, F Yang, N Jiang… - Cell Biology and …, 2021 - Springer
Doxorubicin (DOX) has toxic effects on the heart, causing cardiomyopathy and heart injury,
but the underlying mechanisms of these effects require further investigation. This study …
but the underlying mechanisms of these effects require further investigation. This study …
hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR‐7‐5p and activating the MAPK/ERK signaling …
D Gao, X Qi, X Zhang, K Fang, Z Guo… - Molecular …, 2019 - Wiley Online Library
Emerging research has indicated that circular RNAs (circRNAs), a novel class of non‐coding
RNAs, play a vital role in human tumorigenesis and progression. Our previous results …
RNAs, play a vital role in human tumorigenesis and progression. Our previous results …
Advances in circular RNAs and their roles in breast Cancer
X Wang, L Fang - Journal of Experimental & Clinical Cancer Research, 2018 - Springer
Circular RNAs (circRNAs) are a type of noncoding RNAs with a closed loop structure. With
the development of high-throughput sequencing, massive circRNAs have been discovered …
the development of high-throughput sequencing, massive circRNAs have been discovered …
Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11
D Jiang, X Wu, X Sun, W Tan, X Dai, Y Xie, A Du… - Journal of …, 2022 - Springer
Background Acute myeloid leukemia (AML) is a malignant clonal disease of hematopoietic
stem-and progenitor-cell origin. AML features massive proliferation of abnormal blasts and …
stem-and progenitor-cell origin. AML features massive proliferation of abnormal blasts and …
Functional roles of circular RNAs during epithelial-to-mesenchymal transition
BQ Shang, ML Li, H Quan, PF Hou, ZW Li, SF Chu… - Molecular cancer, 2019 - Springer
Cancer has become a major health issue worldwide, contributing to a high mortality rate.
Tumor metastasis is attributed to the death of most patients. Epithelial-to-mesenchymal …
Tumor metastasis is attributed to the death of most patients. Epithelial-to-mesenchymal …
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
Abstract MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …
[PDF][PDF] A microRNA‐7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib‐resistant cells in human hepatocellular carcinoma
TD Kabir, C Ganda, RM Brown, DJ Beveridge… - …, 2018 - Wiley Online Library
Sorafenib remains the only approved drug for treating patients with advanced hepatocellular
carcinoma (HCC). However, the therapeutic effect of sorafenib is transient, and patients …
carcinoma (HCC). However, the therapeutic effect of sorafenib is transient, and patients …